Health Condition 1: C399- Malignant neoplasm of lower respiratory tract, part unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects of Either Sex age between 23yr-75yr. 2. Subjects suffering from Adenocarcinoma of Lungs, Stomach, Oesophagus, Prostate & Intestine diagnosed with Biopsy. 3.Subjects undergoing Radiation and chemotherapy for above cancer presenting with Side effects. 4.Patients who are presenting adverse effects during/after chemo/radiation. 5.Subject provides written informed consent and gives authorization for use and disclosure of protected health information. 6. Subject agrees not to participate in other clinical trial.
Exclusion criteria
Exclusion criteria: Patients having Adenocarcinoma in more than 3 organs. • Patients undergoing major surgery or H/o Surgery within 3 months. • Patients having adenocarcinoma (Primary) in oral, Breast and brain. • Patients having secondary metastatic Adenocarcinoma in Oral, brain or brain tissue. • Subject has any Genetic diseases(Neurofibromatosis, Haemochromatosis etc) • Subjects SPO2 less than 80 • Subjects having Adenocarcinoma with multi organ failure • Subjects requiring dialysis • Subjects serum is positive for HIV-1 or HIV 2 antibody • Serum positive for Hepatitis B Surface antigen & Hepatitis. • Subject has any underlying or current medical condition, which, in the opinion of the Investigator, would interfere with the evaluation of the subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life assessed with EORTC-QLQ 30), ECOG or appropriate Questionnaires and amelioration of signs and symptomsTimepoint: Baseline, 3weeks, 6weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety profile [Complete blood Count, Serum Creatinine, Serum Urea, SGOT, SGPT, ALP and Total Bilirubin, Total protein] CTCAE Version 5 QuestionnaireTimepoint: Before and After completion | — |
Countries
India
Contacts
Parul Institute of Ayurveda